RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background: The fractional exhaled nitric oxide (FENO) test is useful in asthma patients. However, a few studies on its usefulness in chronic obstructive pulmonary disease (COPD) patients have been reported. We analyzed the FENO level distribution and clinical characteristics according to the FENO level in COPD patients.
Methods: From December 2014 to June 2019, COPD patients who underwent pulmonary function and FENO tests at Chonnam National University Hospital were retrospectively evaluated for FENO, comorbidities, asthma history, blood eosinophil, and pulmonary function test. The high FENO group was defined as those with FENO level>25 parts per billion (ppb).
Results: A total of 849 COPD patients (mean age, 70.3±9.4 years) were included. The mean forced expiratory volume at 1 second was 66.5±21.7% and the mean FENO level was 24.3±20.5 ppb. Patients with FENO ≤25 ppb were 572 (67.4%) and those with FENO >25 ppb were 277 (32.6%). Blood eosinophil percentage was significantly higher (4.2±4.8 vs. 2.7±2.5, p< 0.001) in patients with the high FENO group than the low FENO group. The high FENO group revealed a significantly higher frequency of patients with blood eosinophil percentage >3% (46.9% vs. 34.8%, p=0.001) and asthma history (25.6% vs. 8.6%, p< 0.001) than the lower FENO group. Asthma history, blood eosinophil percentage >3%, and positive bronchodilator response (BDR) were independent risk factors for the high FENO level (adjusted odds ratio [aOR], 3.85; p<0.001; aOR, 1.46; p=0.017; and aOR, 1.57, p=0.034, respectively) in the multivariable analysis.
Conclusion: The FENO level distribution varied in COPD patients and the mean FENO value was slightly elevated. Asthma history, eosinophil percent, and positive BDR were independent risk factors for the high FENO level.

참고문헌 (Reference)

1 Soriano JB, "The proportional Venn diagram of obstructive lung disease : two approximations from the United States and the United Kingdom" 124 : 474-481, 2003

2 Gibson PG, "The overlap syndrome of asthma and COPD : what are its features and how important is it" 64 : 728-735, 2009

3 Global Initiative for Chronic Obstructive Lung Disease, "The global strategy for the diagnosis, management and prevention of COPD" Global Initiative for Chronic Obstructive Lung Disease

4 Wang Z, "The diagnostic accuracy of fractional exhaled nitric oxide testing in asthma : a systematic review and meta-analyses" 93 : 191-198, 2018

5 Zeki AA, "The asthma-COPD overlap syndrome: a common clinical problem in the elderly" 2011 : 861926-, 2011

6 Postma DS, "The asthma-COPD overlap syndrome" 373 : 1241-1249, 2015

7 Juan-juan Fu, "Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome" 대한천식알레르기학회 6 (6): 316-324, 2014

8 Miller MR, "Standardisation of spirometry" 26 : 319-338, 2005

9 Shrestha SK, "Relationship between total serum immunoglobulin E levels, fractional exhaled breath nitric oxide levels and absolute blood eosinophil counts in atopic and non-atopic asthma: a controlled comparative study" 12 : 026009-, 2018

10 Jia-Xi Feng, "Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity" 대한의학회 32 (32): 439-447, 2017